Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 9,500+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

3D printing moulds healthcare innovations

Bio Spectrum

|

September 2021

Pharmaceuticals, bio-medicine, aviation, and automobiles industries have rapidly adopted 3D printing over the years, worldwide, to develop new solutions and prototypes. It is also helping many industries, healthcare, in particular, increase productivity. Despite all its advantages, 3D printing technology is currently posing a number of challenges in the market such as initial costs, limitation to the metals and plastics used for 3D printing, lack of policy standardisation, etc.

- Prabhat Prakash

3D printing moulds healthcare innovations

3D printing has made tremendous contributions throughout healthcare. It has been able to improve clinical outcomes, reduce operation duration and also reduce overall treatment cost. 3D printing has been serving major applications across the globe such as replacing human organ transplants, producing cheaper versions of required surgical tools, speeding up surgical procedures, and improving the lives of patients on prosthetic limbs. Newer tools, advanced technologies are helping in delivering better treatments and devices that are customised to better serve the patient.

As per a recent report by Markets and Research, the global automated 3D printing market was valued at $507.8 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of around 37.14 per cent over the forecast period (2021 - 2026). Although the additive printing market has witnessed growth in India as well, there is still a lot of untapped potential.

Policy standardisation

Despite the potential of 3D printing technology, there is no global policy on the same. Globally industries are looking at 3D printing technology as the technology of the future, governments need to take this into account and try and regulate the sector as and when the need arises. It would be helpful as different countries currently are in different phases of 3D printing technology adoption across industries. For instance, in 2018, China issued guidelines for regulation and registration of 3D printed medical devices which included custom-built additive produced medical devices. China further issued several guidelines for different 3D printed medical devices including a 2020 technical guidance for 3D printed artificial vertebrae and acetabular cups.

MORE STORIES FROM Bio Spectrum

Bio Spectrum

Bio Spectrum

Navigating the Complexities of Pharma Packaging Sustainability

Pharma companies in India are increasingly adopting sustainable methods in packaging to ensure that medicines remain safe and the environment is protected. Various initiatives by the government, focusing on reducing carbon footprints, are revolutionising the pharma packaging industry.

time to read

8 mins

September 2025

Bio Spectrum

Bio Spectrum

Are BioStartUps in a Funding/Innovation Rut?

At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.

time to read

10 mins

September 2025

Bio Spectrum

Bio Spectrum

How Do Recent Deaths Impact Gene Therapy Development?

Cell and gene therapy (CGT) is among the most closely watched areas in pharma and biotech.

time to read

4 mins

September 2025

Bio Spectrum

Bio Spectrum

HealthQuad appoints Namit Chugh as Director

Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Why Is Endoscopy Crucial for Gl Cancer Diagnosis?

The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.

time to read

4 mins

September 2025

Bio Spectrum

New England Biolabs launches NEBNext low-bias small RNA library prep kit

US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels

Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

"Awareness and consistent training are needed with the growing demand for effective skin treatments in India"

India’s dermatology and aesthetic market is reportedly among the fastest-growing globally, projected to grow at a CAGR of 10.11 per cent from 2025 to 2032.

time to read

4 mins

September 2025

Bio Spectrum

Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India

In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr

Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.

time to read

1 min

September 2025

Translate

Share

-
+

Change font size